18 September 2025 │ Presentations and Keynotes

Topas Therapeutics will present its antigen-specific immune tolerance platform at BioCentury’s Grand Rounds Europe in Cambridge on 18 September 2026. The presentation will highlight Topas’ antigen-specific immune tolerance platform for autoimmune and antigen-driven diseases, including progress in celiac disease and type 1 diabetes.